How many drugs treat Hypercalcemia?

Drug Landscape tracks 4 marketed treatments for Hypercalcemia (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/hypercalcemia.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Hypercalcemia — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hypercalcemia (disease) competitive landscape: 4 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

4 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Hypercalcemia, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Boniva	IBANDRONIC ACID	Hoffmann La Roche	Bisphosphonate	Farnesyl pyrophosphate synthase	2003-01-01
Calcium Disodium Versenate	EDETIC ACID	Medicis	Anti-coagulant	Amyloid beta A4 protein	1953-01-01
Ibandronate	Ibandronate	University of California, San Francisco		Geranylgeranyl pyrophosphate synthase, Farnesyl pyrophosphate synthase, Farnesyl pyrophosphate synthase
bonviva	bonviva	Alvogen Korea		Geranylgeranyl pyrophosphate synthase, Farnesyl pyrophosphate synthase, Farnesyl pyrophosphate synthase

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Alvogen Korea · 1 drug in Hypercalcemia
Hoffmann La Roche · 1 drug in Hypercalcemia
Medicis · 1 drug in Hypercalcemia
University of California, San Francisco · 1 drug in Hypercalcemia

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Hypercalcemia:

Cite this brief

Drug Landscape (2026). Hypercalcemia — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/hypercalcemia. Accessed 2026-06-10.

Hypercalcemia full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing